Literature DB >> 31269856

Spinocerebellar ataxia type 7 with RP1L1-negative occult macular dystrophy as retinal manifestation.

Jun Young Park1, Seo Young Wy1, Kwangsic Joo1, Se Joon Woo1.   

Abstract

Background: Spinocerebellar ataxia Type 7 (SCA7) is an autosomal dominant, progressive neurodegenerative disorder, primarily characterized by cerebellar ataxia. The disease is caused by the expansion of a CAG trinucleotide repeat within the ataxin-7 gene when its CAG repeat sequences are extended beyond 38. The degree of retinopathy can vary from pigment change in the fovea to foveal atrophy and is correlated with the number of CAG repeats. The present study describes a case of SCA7 with a retinal presentation similar to occult macular dystrophy (OMD) which is an inherited macular dystrophy characterized by presenting with a normal fundus and fluorescein angiography but with progressive central visual loss. Materials and
Methods: Report of a case.
Results: In this case, no specific abnormality was found on fundus examination, fluorescein angiography, full-field electroretinography and infrared autofluorescence. Spectral-domain optical coherence tomography showed foveal thinning, focal disruption of the ellipsoid zone, and central loss of the outer segment-retinal pigment epithelium interdigitation zone that were well matched with the multifocal electroretinography finding. Thirty-nine CAG repeats in ataxin-7 gene were identified through genetic testing. Conclusions: SCA7 can present with a very mild form of retinal degeneration similar to the classic phenotype of RP1L1-negative OMD in case of the lower number of CAG repeats.

Entities:  

Keywords:  SCA7; Spinocerebellar ataxia type 7; occult macular dystrophy; retinal degeneration

Mesh:

Substances:

Year:  2019        PMID: 31269856     DOI: 10.1080/13816810.2019.1633548

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  2 in total

1.  Progress of macular atrophy during 30 months' follow-up in a patient with spinocerebellar ataxia type1 (SCA1).

Authors:  Ayane Hirose; Satoshi Katagiri; Takaaki Hayashi; Tomokazu Matsuura; Norihiro Nagai; Kaoru Fujinami; Takeshi Iwata; Kazushige Tsunoda
Journal:  Doc Ophthalmol       Date:  2020-07-09       Impact factor: 2.379

2.  Clinical characterization and the improved molecular diagnosis of autosomal dominant cone-rod dystrophy in patients with SCA7.

Authors:  Xuan Zou; Fengxia Yao; Fengrong Li; Shijing Wu; Hui Li; Zixi Sun; Tian Zhu; Xing Wei; Donghui Li; Ruifang Sui
Journal:  Mol Vis       Date:  2021-05-07       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.